Smoking among Chinese patients with schizophrenia

References

• De Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. American Journal of Psychiatry 1995; 152: 453–455
   PubMed Web of Science ®Google Scholar
• Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992; 149: 1189–1194
   PubMed Web of Science ®Google Scholar
• Gopalaswamy AK, Morgan R. Smoking in chronic schizophrenia [letter|. British Journal of Psychiatry 1986; 149: 523
   PubMed Web of Science ®Google Scholar
• Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 1986; 143: 993–997
   PubMed Web of Science ®Google Scholar
• Masterson E, O'Shea B. Smoking and malignancy in schizophrenia. British Journal of Psychiatry 1984; 145: 429–432
   PubMed Web of Science ®Google Scholar
• Decina P, Caracci G, Sandik R, Berman W, Mukherjee S, Scapicchio PL. Cigarette smoking and neuroleptic-induced parkinsonism. Biological Psychiatry 1990; 28: 502–508
   PubMed Web of Science ®Google Scholar
• Vinarova E, Vinar O, Kalvach Z. Smokers need higher doses of neuroleptic drugs. Biological Psychiatry 1984; 19: 1265–1268
   PubMedGoogle Scholar
• Jann MW, Saklad SR, Ereshesky L, Richards AL, Harrington CA, Davis CM. Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology 1986; 90: 468–470
   PubMed Web of Science ®Google Scholar
• Miller LG. Cigarettes and drug therapy: pharmacokinetic and pharmacodynamic considerations. Clinical Pharmacology 1990; 9: 125–135
   PubMedGoogle Scholar
• Rudorfer MV. Pharmacokinetics of psychotropic drugs in special populations. Journal of Clinical Psychiatry 1993; 59 (Suppl. 9): 50–54
   Google Scholar
• Potkin SG, Shen Y, Pardes H. Haloperidol concentrations elevated in Chinese patients. Psychiatry Research 1984; 12: 167–172
   PubMedGoogle Scholar
• Bertilsson L, Lou YQ, Du YL. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquone and S-mephenytoin. Clinical Pharmacology and Therapeutics 1992; 51: 388–392
   PubMed Web of Science ®Google Scholar
• Lou YC. Ying L. Bertilsson, Sjoqvist F. Low frequency of debrisoquine hydroxylation in a native Chinese population. Lancet 1987; 2: 852
   Google Scholar
• Lee EJD, Yeoh PN, Gong NH. Oxidation phenotyping in Chinese and Malay populations. Clinical Experimental Pharmacology and Physiology 1988; 15: 889–891
   PubMedGoogle Scholar
• Kalow W. Genetic variation in the human hepatic cytochrome P450 system. European Journal of Clinical Pharmacology 1987; 31: 633–641
   PubMed Web of Science ®Google Scholar
• Binder RL, Levy R. Extrapyramidal reactions in Asians. American Journal of Psychiatry 1981; 138: 1241–1244
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., revised. Washington: American Psychiatric Association,. 1987
   Google Scholar
• Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962; 10: 799–812
   Web of Science ®Google Scholar
• Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 1970; 45: 11–19
   Google Scholar
• Davis JM. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861
   PubMed Web of Science ®Google Scholar
• Lader M, Herrington R. Psychoses and antipsychotic medications. In: Biological treatments in psychiatry. Oxford: Oxford University Press,. 1990; 216–257
   Google Scholar
• Research and Evaluation Department, Ministry of Health, Singapore. National health survey 1992. Research and Evaluation Department, Ministry of Health, Singapore,. 1993
   Google Scholar
• Anderson K, Fuxe K, Agnati LF. Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Acta Physiologica Scandinavica 1981; 112: 345–347
   PubMedGoogle Scholar
• Grenhoff J, Aston Jones G, Svensson TH. The nicotinic effects on the firing pattern midbrain dopamine neurons. Acta Physiologica Scandinavica 1986; 128: 351–358
   PubMedGoogle Scholar
• Wise RA, Bozarth MA. Brain reward circuitry: four circuit elements ‘wired’ in apparent series. Brain Research Bulletin 1984; 12: 203–208
   PubMed Web of Science ®Google Scholar
• Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 712–723
   Google Scholar
• Glassman AH. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 1993; 150: 546–553
   PubMed Web of Science ®Google Scholar
• MacKay AVP. Positive and negative schizophrenic symptoms and the role of dopamine: discussion, 1. British Journal of Psychiatry 1980; 137: 379–383
   PubMed Web of Science ®Google Scholar
• Di Chiara G, Imperato A. Drugs abused by humans preferentially increase in synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences (USA). 1972; 5274–5278
   Google Scholar
• Gardner EL. Brain reward mechanisms. Comprehensive textbook of substance abuse. 2nd ed, JH Lowinson, P Ruiz, RB Millman. Williams and Wilkins, Baltimore 1992
   Google Scholar
• Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenia patients. British Journal of Psychiatry 1993; 163: 183–189
   PubMed Web of Science ®Google Scholar